2022 in review: Senior execs weigh in on greatest technological advances in 2022
As the year draws to a close, Outsourcing-Pharma caught up with some senior executives for a three-part series looking back on an eventful 2022, and look ahead to 2023.
As the year draws to a close, Outsourcing-Pharma caught up with some senior executives for a three-part series looking back on an eventful 2022, and look ahead to 2023.
Pfizer receives additional orders for its COVID-19 treatment, after US requests more doses, and several Chinese companies are also reported to have begun selling the product.
Senior executives at Greenphire, a leader in financial lifecycle management for clinical trials, share their 2023 predictions.
Rx Health will host Wise Therapeutics’ game-based digital therapeutic, as part of its broader health plan and system.